Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1513
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
Sharon H. Giordano,Maria Alice B. Franzoi,Sarah Temin,Carey K. Anders,Sarat Chandarlapaty,Jennie R. Crews,Jeffrey J. Kirshner,Ian E. Krop,Nancy U. Lin,Aki Morikawa,Debra A. Patt,Jane Perlmutter,Naren Ramakrishna,Nancy E. Davidson
Journal of Clinical Oncology.2022;40(23)2612
[DOI]
2Comparative efficacy and safety of trastuzumab biosimilars to the reference drug: a systematic review and meta-analysis of randomized clinical trials
Sarah Cargnin,Jae Il Shin,Armando A. Genazzani,Alessia Nottegar,Salvatore Terrazzino
Cancer Chemotherapy and Pharmacology.2020;86(5)577
[DOI]
3Trastuzumab biosimilars vs trastuzumab originator in the treatment of HER2-positive breast cancer: a systematic review and network meta-analysis
Tong Liu,Duo Liu,Yao Jin,Mei Dong
Immunopharmacology and Immunotoxicology.2022;86(5)1
[DOI]
  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow